PartnershipMar 29, 2026, 09:13 PM
Amgen Terminates License and Collaboration Agreement with Kyowa Kirin
AI Summary
Amgen has entered into a Termination Agreement with Kyowa Kirin to end their License and Collaboration Agreement, effective upon regulatory approval. The original agreement was dated June 1, 2021, and the termination could impact Amgen's future revenue streams and research collaborations.
Key Highlights
- Amgen and Kyowa Kirin agreed to terminate their License and Collaboration Agreement dated June 1, 2021.
- The termination will become effective upon receipt of regulatory approval.
- The Termination Agreement is filed as Exhibit 10.1.
Price Impact
More from AMGN